Nurt.Bo
Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.
Business. Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nurtures is a food and drug retailing company operating in the Consumer Non-Cyclicals sector, primarily generating revenue through the sale of food and drug products to consumers.
Nurtures maintains a strong liquidity position, as evidenced by a current ratio of 1.61, indicating that the company has sufficient current assets to cover its current liabilities. The company's liquidity is further supported by a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing and a strong equity base. The operating cash flow of INR 480.9 million and free cash flow of INR 65.93 million indicate that the company generates positive cash from operations, which can be used for reinvestment or shareholder returns.
In terms of profitability, Nurtures demonstrates a return on equity (ROE) of 21.69% and a return on assets (ROA) of 11.69%, both of which are strong indicators of efficient use of equity and assets to generate profits. These metrics are particularly significant in the Food Retail & Distribution industry, where margins are typically compressed due to competitive pricing and high operational costs. The company's gross profit of INR 1.03 billion and operating income of INR 659.5 million further support its profitability.
Nurtures operates primarily in the food and drug retailing segment, with a focus on domestic markets. The company's revenue is concentrated in this segment, and there is no indication of significant geographic diversification in the provided data. This concentration may expose the company to regional economic fluctuations and regulatory changes, which could impact its overall performance.
The company's growth trajectory is supported by its strong operating cash flow and free cash flow, which provide flexibility for expansion and investment. However, the absence of detailed revenue history and outlook data makes it challenging to assess the company's future growth potential. The company's capital expenditure of INR -34 million suggests that it is not currently investing heavily in new projects or infrastructure, which may limit its ability to scale operations.
Nurtures faces a medium liquidity risk, as indicated by the risk assessment, and the company has a negative net cash position after accounting for total debt. The dilution risk could not be assessed due to the absence of basic and diluted share counts, which is a limitation in evaluating potential shareholder dilution. The company's low debt levels and strong equity position mitigate some of these risks, but the lack of detailed information on capital structure and shareholder dilution remains a concern.
There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial performance. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments, which could affect investor confidence and market perception.
- Nurtures has a strong liquidity position with a current ratio of 1.61 and a low debt-to-equity ratio of 0.01.
- The company demonstrates high profitability with a return on equity of 21.69% and a return on assets of 11.69%.
- Nurtures' revenue is concentrated in the food and drug retailing segment, with no significant geographic diversification.
- The company's growth trajectory is supported by positive operating and free cash flows, but the lack of detailed revenue history limits the assessment of future growth potential.
- Nurtures faces a medium liquidity risk and an unassessable dilution risk due to missing share count data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- NURT.BO Market data — financials · 2026-05-28